Alison C. Purcell

Alison C. Purcell

Auto-generated profile, based on publicly available information

Alison C. Purcell

Institute of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2022 in Nature Medicine
Verified
Journal Article
Open access
PDF file
NRNeil A. Robertson
Neil A. Robertson
ELEric Latorre-Crespo
Eric Latorre-Crespo
MTMaria Terradas-Terradas
Maria Terradas-Terradas
JLJorge Lemos-Portela
Jorge Lemos-Portela
APAlison C. Purcell
Alison C. Purcell
TCTamir Chandra
Tamir Chandra
Clonal hematopoiesis of indeterminate potential (CHIP) increases rapidly in prevalence beyond age 60 and has been associated with increased risk for malignancy, heart disease and ischemic stroke. CHIP is driven by somatic mutations in hematopoietic stem and progenitor cells (HSPCs). Because mutations in HSPCs often drive leukemia, we hypothesized that HSPC fitness substantially contributes to transformation from CHIP to leukemia. HSPC fitness is defined as the proliferative advantage over cells carrying no or only neutral mutations. If mutations in different genes lead to distinct fitness advantages, this could enable patient stratification. We quantified the fitness effects of mutations over 12 years in older age using longitudinal sequencing and developed a filtering method that considers individual mutational context alongside mutation co-occurrence to quantify the growth potential of variants within individuals. We found that gene-specific fitness differences can outweigh inter-individual variation and, therefore, could form the basis for personalized clinical management.